CLINICAL_TRIALS
trial_result
· 2016-09-02
Clinical Trial Update: PERmixon® in LUTS Evaluation Study (PERLES) [Phase 4]
Summary
A Phase 4 clinical trial update for PERmixon in lower urinary tract symptoms due to benign prostatic hyperplasia (PERLES) has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pierre Fabre Medicament | Conditions: Benign Prostatic Hyperplasia (BPH) | Phase 4 | Status: COMPLETED